Mereo BioPharma Group PLC (MREO)
NASDAQ
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Return on Assets (%) | -44.84 | -42.38 | -39.153 | -45.333 | -219.053 | 13.44 | -31.574 | -45.263 |
Return on Equity (%) | -49.374 | -54.747 | -67.25 | -95.428 | -1294.269 | 34.848 | -44.156 | -59.334 |
Return on Invested Capital (%) | -51.623 | -45.69 | -46.517 | -59.804 | -131.295 | -35.497 | -49.008 | -53.997 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | 50.085 | N/A | -417.046 |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | 34.897 | N/A | -419.282 |
Book Value Per Share | 0.831 | 0.415 | 0.002 | -0.043 | -0.138 | 0.108 | 0.068 | 0.054 |
Earnings Per Share | -0.441 | -0.546 | -0.45 | -0.356 | -0.483 | 0.022 | -0.053 | -0.047 |
Cash Per Share | 0.833 | 0.704 | 0.352 | 0.167 | 0.069 | 0.161 | 0.09 | 0.064 |
Working Capital Per Share | 0.895 | 0.753 | 0.257 | 0.006 | 0.062 | 0.148 | 0.067 | 0.061 |
Operating Profit Per Share | N/A | N/A | N/A | 0.026 | N/A | 0.033 | 0.003 | -0.006 |
EBIT Per Share | -0.524 | -0.66 | -0.524 | -0.42 | -0.491 | 0.024 | -0.056 | -0.049 |
EBITDA Per Share | -0.524 | -0.66 | -0.524 | -0.42 | -0.491 | 0.024 | -0.056 | -0.049 |
Free Cash Flow Per Share | -0.442 | -0.514 | -0.45 | -0.371 | -0.487 | 0.022 | -0.054 | -0.049 |
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | 64.34M | 71.1M | 71.24M | 97.96M | 338.95M | 584.96M | 624.93M | 701.22M |
Year End December 30 2023 | ||||||||
---|---|---|---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Shares Outstanding | N/A | |||||||
Return on Assets (%) | N/A | |||||||
Return on Equity (%) | N/A | |||||||
Return on Invested Capital (%) | N/A | |||||||
Operating Margin (%) | N/A | |||||||
Net Profit Margin (%) | N/A | |||||||
Sales Per Share | N/A | |||||||
Book Value Per Share | N/A | |||||||
Earnings Per Share | N/A | |||||||
Cash Per Share | N/A | |||||||
Working Capital Per Share | N/A | |||||||
Operating Profit Per Share | N/A | |||||||
EBIT Per Share | N/A | |||||||
EBITDA Per Share | N/A | |||||||
Free Cash Flow Per Share | N/A | |||||||
Current Ratio | N/A | |||||||
Quick Ratio | N/A | |||||||
Inventory Turnover (Days) | N/A |
Market Cap | 498.02M |
Price to Earnings Ratio | -15.01 |
Price to Sales Ratio | 61.97 |
Price to Cash Ratio | 11.04 |
Price to Book Ratio | 10.1 |
Dividend Yield | - |
Shares Outstanding | 155.15M |
Average Volume (1 week) | 752.07k |
Average Volume (1 Month) | 1.28M |
52 Week Change | -21.71% |
52 Week High | 5.02 |
52 Week Low | 2.525 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.